JEVTANA KIT

Jevtana Kit Adverse Events Reported to the FDA Over Time

How are Jevtana Kit adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Jevtana Kit, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Jevtana Kit is flagged as the suspect drug causing the adverse event.

Most Common Jevtana Kit Adverse Events Reported to the FDA

What are the most common Jevtana Kit adverse events reported to the FDA?

Death	61 (6.2%)
Neutropenia	34 (3.46%)
Thrombocytopenia	30 (3.05%)
Anaemia	25 (2.54%)
Diarrhoea	22 (2.24%)
Pulmonary Embolism	18 (1.83%)
Renal Failure	18 (1.83%)
Asthenia	17 (1.73%)
Pancytopenia	16 (1.63%)
Disease Progression	15 (1.52%)
Dyspnoea	15 (1.52%)
	Show More
Pneumonia	15 (1.52%)
Abdominal Pain	14 (1.42%)
Gastrointestinal Haemorrhage	14 (1.42%)
Pyrexia	14 (1.42%)
Atrial Fibrillation	12 (1.22%)
Decreased Appetite	12 (1.22%)
Nausea	12 (1.22%)
Sepsis	12 (1.22%)
Constipation	11 (1.12%)
Disseminated Intravascular Coagulat...	10 (1.02%)
General Physical Health Deteriorati...	10 (1.02%)
Hypotension	10 (1.02%)
Febrile Neutropenia	9 (.91%)
Ileus	9 (.91%)
Chest Pain	8 (.81%)
Fatigue	8 (.81%)
Respiratory Failure	8 (.81%)
Spinal Cord Compression	8 (.81%)
Arrhythmia	7 (.71%)
Confusional State	7 (.71%)
Convulsion	7 (.71%)
Febrile Bone Marrow Aplasia	7 (.71%)
Lung Infiltration	7 (.71%)
Pleural Effusion	7 (.71%)
Rectal Haemorrhage	7 (.71%)
Septic Shock	7 (.71%)
Weight Decreased	7 (.71%)
Condition Aggravated	6 (.61%)
Delirium	6 (.61%)
Hallucination	6 (.61%)
Vomiting	6 (.61%)
Bacterial Sepsis	5 (.51%)
Dizziness	5 (.51%)
Gastric Haemorrhage	5 (.51%)
Haemoglobin Decreased	5 (.51%)
Haemoptysis	5 (.51%)
Multi-organ Failure	5 (.51%)
Neuropathy Peripheral	5 (.51%)
Oedema Peripheral	5 (.51%)
Sudden Death	5 (.51%)
Abscess	4 (.41%)
Anuria	4 (.41%)
Atrial Flutter	4 (.41%)
Blood Glucose Abnormal	4 (.41%)
Blood Lactate Dehydrogenase Increas...	4 (.41%)
Bone Pain	4 (.41%)
Cardiac Arrest	4 (.41%)
Cholestasis	4 (.41%)
Chronic Obstructive Pulmonary Disea...	4 (.41%)
Clostridium Difficile Colitis	4 (.41%)
Cold Type Haemolytic Anaemia	4 (.41%)
Dehydration	4 (.41%)
Disorientation	4 (.41%)
Drug Ineffective	4 (.41%)
Extravasation	4 (.41%)
Flushing	4 (.41%)
Haematuria	4 (.41%)
Hepatic Failure	4 (.41%)
Hypovolaemia	4 (.41%)
Melaena	4 (.41%)
Muscle Rigidity	4 (.41%)
Muscle Spasms	4 (.41%)
Neurotoxicity	4 (.41%)
Neutropenic Infection	4 (.41%)
Pneumonitis	4 (.41%)
Pulmonary Haemorrhage	4 (.41%)
Renal Failure Acute	4 (.41%)
Tremor	4 (.41%)
Unresponsive To Stimuli	4 (.41%)
White Blood Cell Count Decreased	4 (.41%)
Acute Coronary Syndrome	3 (.3%)
Acute Pulmonary Oedema	3 (.3%)
Acute Respiratory Distress Syndrome	3 (.3%)
Ageusia	3 (.3%)
Alanine Aminotransferase Increased	3 (.3%)
Aphagia	3 (.3%)
Aspartate Aminotransferase Increase...	3 (.3%)
Blood Alkaline Phosphatase Decrease...	3 (.3%)
Blood Bilirubin Increased	3 (.3%)
Coronary Artery Occlusion	3 (.3%)
Diverticular Perforation	3 (.3%)
Intestinal Perforation	3 (.3%)
Pain	3 (.3%)
Petechiae	3 (.3%)
Proctitis	3 (.3%)
Prostate Cancer	3 (.3%)
Prostatic Specific Antigen Increase...	3 (.3%)
Stevens-johnson Syndrome	3 (.3%)
Syncope	3 (.3%)
Tachycardia	3 (.3%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Jevtana Kit, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Jevtana Kit is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Jevtana Kit

What are the most common Jevtana Kit adverse events reported to the FDA?

Fatal Outcomes	66 (6.71%)
Infections - Pathogen Unspecified	56 (5.69%)
Anemias Nonhemolytic And Marrow Dep...	49 (4.98%)
White Blood Cell	48 (4.88%)
Gastrointestinal Signs	37 (3.76%)
Respiratory	37 (3.76%)
Gastrointestinal Hemorrhages	36 (3.66%)
Gastrointestinal Motility And Defec...	33 (3.35%)
Platelet	33 (3.35%)
Cardiac Arrhythmias	32 (3.25%)
Neurological	31 (3.15%)
	Show More
Renal Disorders	27 (2.74%)
Lower Respiratory Tract Disorders	20 (2.03%)
Pulmonary Vascular	19 (1.93%)
Deliria	17 (1.73%)
Hematology Investigations	16 (1.63%)
Electrolyte And Fluid Balance Condi...	15 (1.52%)
Body Temperature Conditions	14 (1.42%)
Appetite And General Nutritional	13 (1.32%)
Coronary Artery	12 (1.22%)
Muscle	12 (1.22%)
Bacterial Infectious	11 (1.12%)
Gastrointestinal Ulceration And Per...	11 (1.12%)
Hepatobiliary	11 (1.12%)
Coagulopathies And Bleeding Diathes...	10 (1.02%)
Decreased And Nonspecific Blood Pre...	10 (1.02%)
Epidermal And Dermal Conditions	9 (.91%)
Gastrointestinal Stenosis And Obstr...	9 (.91%)
Hepatic And Hepatobiliary	9 (.91%)
Enzyme	8 (.81%)
Hemolyses And Related Conditions	8 (.81%)
Procedural And Device Related Injur...	8 (.81%)
Spinal Cord And Nerve Root	8 (.81%)
Urinary Tract Signs	8 (.81%)
Metabolic, Nutritional And Blood Ga...	7 (.71%)
Peripheral Neuropathies	7 (.71%)
Physical Examination Topics	7 (.71%)
Pleural	7 (.71%)
Seizures	7 (.71%)
Bone Disorders	6 (.61%)
Disturbances In Thinking	6 (.61%)
Movement Disorders	6 (.61%)
Therapeutic And Nontherapeutic Effe...	6 (.61%)
Vascular	5 (.51%)
Water, Electrolyte And Mineral	5 (.51%)
Bronchial Disorders	4 (.41%)
Gastrointestinal Inflammatory Condi...	4 (.41%)
Heart Failures	4 (.41%)
Metastases	4 (.41%)
Pericardial	4 (.41%)
Skin Vascular Abnormalities	4 (.41%)
Cardiac And Vascular Investigations	3 (.3%)
Glucose Metabolism Disorders	3 (.3%)
Immunology And Allergy	3 (.3%)
Injuries	3 (.3%)
Neoplasm Related Morbidities	3 (.3%)
Reproductive Neoplasms Male Maligna...	3 (.3%)
Administration Site Reactions	2 (.2%)
Bladder And Bladder Neck Disorders	2 (.2%)
Bone, Calcium, Magnesium And Phosph...	2 (.2%)
Cardiac Disorder Signs	2 (.2%)
Central Nervous System Vascular	2 (.2%)
Congenital And Hereditary	2 (.2%)
Embolism And Thrombosis	2 (.2%)
Hematopoietic Neoplasms	2 (.2%)
Leukemias	2 (.2%)
Microbiology And Serology	2 (.2%)
Musculoskeletal And Connective Tiss...	2 (.2%)
Peritoneal And Retroperitoneal Cond...	2 (.2%)
Protein And Amino Acid Metabolism	2 (.2%)
Sleep Disorders	2 (.2%)
Suicidal And Self-injurious Behavio...	2 (.2%)
Bone And Joint Injuries	1 (.1%)
Exocrine Pancreas Conditions	1 (.1%)
Gastrointestinal Vascular Condition...	1 (.1%)
Hearing	1 (.1%)
Joint	1 (.1%)
Miscellaneous And Site Unspecified ...	1 (.1%)
Protozoal Infectious	1 (.1%)
Psychiatric And Behavioural Symptom...	1 (.1%)
Skin And Subcutaneous Tissue	1 (.1%)
Therapeutic Procedures And Supporti...	1 (.1%)
Upper Respiratory Tract Disorders	1 (.1%)
Urolithiases	1 (.1%)
Vascular Hemorrhagic	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Jevtana Kit, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Jevtana Kit is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.